🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 17% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
50 Servings
Botanical with Nutrients Product Type
17% Evidence Coverage

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
Vitamin C
20 mg (33% DV)
Calcium
72 mg (7% DV)
140 mg (35% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 140mg
📊 Market median: 380.0mg (120 products) 📚 8 studies — no high-quality reviews
This product: 400mg
100 mg
📊 Market median: 380.0mg (120 products) 📚 8 studies — no high-quality reviews
This product: 100mg

Other Ingredients

Sorbitol Stearic Acid modified Cellulose Gum Silica

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (67% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: 1 or 2 tablets daily between meals.

⚠️ Warnings & Precautions

Note: If you are pregnant, may become pregnant, or breastfeeding, consult your health care professional before using this product.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

🧪 Formulation Notes

Feverfew (Tanacetum parthenium) is a member of the daisy family. Its extract has been shown in human cell culture studies to inhibit the synthesis of prostaglandins known to cause physical discomfort. Further research needs to be conducted to confirm its effects, if any, in humans.

Product Details

UPC / SKU 0 21078 00209 3
DSLD Entry Date 2019-12-22
Product Type Botanical with Nutrients
Form Tablet or Pill
DSLD ID 211659
Data Updated 2026-04-11

Research Evidence

10 Research Sources
48 Avg Quality Score
4 Systematic Review
4 Rct
1 Meta Analysis
1 Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985
View all evidence for Feverfew →

Compare Similar Products

View all Feverfew products →